• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

耐多药革兰氏阴性菌体外协同检测方法的比较

Comparison of methods for the detection of in vitro synergy in multidrug-resistant gram-negative bacteria.

作者信息

Gaudereto Juliana Januario, Neto Lauro Vieira Perdigão, Leite Gleice Cristina, Espinoza Evelyn Patricia Sanchez, Martins Roberta Cristina Ruedas, Villas Boa Prado Gladys, Rossi Flavia, Guimarães Thais, Levin Anna Sara, Costa Silvia Figueiredo

机构信息

Laboratório de Investigação Médica 49 - LIM-49, Instituto de Medicina Tropical, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo, Avenida Doutor Enéas de Carvalho Aguiar, 470, São Paulo, SP, 05403-000, Brazil.

Divisão de Laboratório Central - Serviço de Microbiologia Clínica, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brazil.

出版信息

BMC Microbiol. 2020 Apr 16;20(1):97. doi: 10.1186/s12866-020-01756-0.

DOI:10.1186/s12866-020-01756-0
PMID:32299353
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7161189/
Abstract

BACKGROUND

The use of combined antibiotic therapy has become an option for infections caused by multidrug-resistant (MDR) bacteria. The time-kill (TK) assay is considered the gold standard method for the evaluation of in vitro synergy, but it is a time-consuming and expensive method. The purpose of this study was to evaluate two methods for testing in vitro antimicrobial combinations: the disk diffusion method through disk approximation (DA) and the agar gradient diffusion method via the MIC:MIC ratio. The TK assay was included as the gold standard. MDR Gram-negative clinical isolates (n = 62; 28 Pseudomonas aeruginosa, 20 Acinetobacter baumannii, and 14 Serratia marcescens) were submitted to TK, DA, and MIC:MIC ratio synergy methods.

RESULTS

Overall, the agreement between the DA and TK assays ranged from 20 to 93%. The isolates of A. baumannii showed variable results of synergism according to TK, and the calculated agreement was statistically significant in this species against fosfomycin with meropenem including colistin-resistant isolates. The MIC:MIC ratiometric agreed from 35 to 71% with TK assays. The kappa test showed good agreement for the combination of colistin with amikacin (K = 0.58; P = 0.04) among the colistin-resistant A. baumannii isolates.

CONCLUSIONS

The DA and MIC:MIC ratiometric methods are easier to perform and might be a more viable tool for clinical microbiology laboratories.

摘要

背景

联合抗生素治疗已成为耐多药(MDR)细菌所致感染的一种选择。时间杀菌(TK)试验被认为是评估体外协同作用的金标准方法,但它是一种耗时且昂贵的方法。本研究的目的是评估两种测试体外抗菌联合作用的方法:通过纸片逼近法(DA)的纸片扩散法和通过MIC:MIC比值的琼脂梯度扩散法。将TK试验作为金标准纳入。对62株耐多药革兰氏阴性临床分离株(28株铜绿假单胞菌、20株鲍曼不动杆菌和14株粘质沙雷氏菌)进行了TK、DA和MIC:MIC比值协同作用方法的检测。

结果

总体而言,DA试验与TK试验之间的一致性范围为20%至93%。鲍曼不动杆菌分离株根据TK试验显示出不同的协同作用结果,在该菌种中,对于磷霉素与美罗培南联合使用(包括耐粘菌素分离株),计算得出的一致性具有统计学意义。MIC:MIC比值法与TK试验的一致性为35%至71%。kappa检验显示,在耐粘菌素的鲍曼不动杆菌分离株中,粘菌素与阿米卡星联合使用具有良好的一致性(K = 0.58;P = 0.04)。

结论

DA法和MIC:MIC比值法操作更简便,可能是临床微生物实验室更可行的工具。

相似文献

1
Comparison of methods for the detection of in vitro synergy in multidrug-resistant gram-negative bacteria.耐多药革兰氏阴性菌体外协同检测方法的比较
BMC Microbiol. 2020 Apr 16;20(1):97. doi: 10.1186/s12866-020-01756-0.
2
[Evaluation of In vitro Efficacy of Meropenem/Colistin and Meropenem/Fosfomycin Combinations on Multidrug Resistant Gram-Negative Bacilli].美罗培南/黏菌素和美罗培南/磷霉素联合用药对多重耐药革兰阴性杆菌的体外疗效评估
Mikrobiyol Bul. 2023 Jul;57(3):365-377. doi: 10.5578/mb.20239930.
3
Evaluation of the Synergy of Ceftazidime-Avibactam in Combination with Meropenem, Amikacin, Aztreonam, Colistin, or Fosfomycin against Well-Characterized Multidrug-Resistant Klebsiella pneumoniae and Pseudomonas aeruginosa.评价头孢他啶-阿维巴坦与美罗培南、阿米卡星、氨曲南、黏菌素或磷霉素联合使用对经过充分特征鉴定的多药耐药肺炎克雷伯菌和铜绿假单胞菌的协同作用。
Antimicrob Agents Chemother. 2019 Jul 25;63(8). doi: 10.1128/AAC.00779-19. Print 2019 Aug.
4
Activity of Ceftazidime-Avibactam Alone and in Combination with Amikacin Against Colistin-Resistant Gram-Negative Pathogens.头孢他啶-阿维巴坦单独及联合阿米卡星对多黏菌素耐药革兰氏阴性病原菌的活性。
Microb Drug Resist. 2021 Mar;27(3):401-409. doi: 10.1089/mdr.2019.0463. Epub 2020 Jul 24.
5
Ultrastructural changes caused by the combination of intravenous immunoglobulin with meropenem, amikacin and colistin in multidrug-resistant Acinetobacter baumannii.静脉注射用免疫球蛋白联合美罗培南、阿米卡星和黏菌素对多重耐药鲍曼不动杆菌的超微结构改变。
Microb Pathog. 2020 Dec;149:104437. doi: 10.1016/j.micpath.2020.104437. Epub 2020 Oct 9.
6
Systematic review and meta-analysis of in vitro efficacy of antibiotic combination therapy against carbapenem-resistant Gram-negative bacilli.抗生素联合治疗对碳青霉烯类耐药革兰氏阴性杆菌体外疗效的系统评价和荟萃分析。
Int J Antimicrob Agents. 2021 May;57(5):106344. doi: 10.1016/j.ijantimicag.2021.106344. Epub 2021 Apr 20.
7
Isothermal microcalorimetry vs checkerboard assay to evaluate in-vitro synergism of meropenem-amikacin and meropenem-colistin combinations against multi-drug-resistant Gram-negative pathogens.等温微量热法与棋盘微量稀释法评价美罗培南-阿米卡星和美罗培南-黏菌素联合治疗多重耐药革兰阴性病原菌的体外协同作用。
Int J Antimicrob Agents. 2022 Oct;60(4):106668. doi: 10.1016/j.ijantimicag.2022.106668. Epub 2022 Aug 28.
8
In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.非传统抗菌药物单独或联合使用对从重症监护病房分离出的多重耐药铜绿假单胞菌和鲍曼不动杆菌菌株的体外活性。
Int J Antimicrob Agents. 2006 Mar;27(3):224-8. doi: 10.1016/j.ijantimicag.2005.10.012. Epub 2006 Feb 7.
9
Colistin MIC variability by method for contemporary clinical isolates of multidrug-resistant Gram-negative bacilli.多药耐药革兰氏阴性杆菌临床分离株中不同方法检测黏菌素 MIC 值的差异。
J Clin Microbiol. 2013 Jun;51(6):1678-84. doi: 10.1128/JCM.03385-12. Epub 2013 Mar 13.
10
In vitro activities of ceftazidime/avibactam alone or in combination with antibiotics against multidrug-resistant Acinetobacter baumannii isolates.头孢他啶/阿维巴坦单独或联合抗生素对多重耐药鲍曼不动杆菌分离株的体外活性。
J Glob Antimicrob Resist. 2019 Jun;17:137-141. doi: 10.1016/j.jgar.2018.12.004. Epub 2018 Dec 18.

引用本文的文献

1
In Vitro Evaluation of Antimicrobial Synergy Against Multidrug-Resistant Gram-Negative Paediatric Bloodstream Pathogens in South Africa.南非针对多重耐药革兰氏阴性儿科血流病原体的抗菌协同作用的体外评估
Antibiotics (Basel). 2025 Jun 20;14(7):630. doi: 10.3390/antibiotics14070630.
2
Salvage Therapy Against Infections of MDR Achieved by Synergistic Effect of Colistin-Containing Therapies-Preliminary Study.含黏菌素疗法协同效应实现的耐多药感染挽救治疗——初步研究
Microorganisms. 2025 May 25;13(6):1206. doi: 10.3390/microorganisms13061206.
3
In Vitro Activity of Cefaclor/Beta-Lactamases Inhibitors (Clavulanic Acid and Sulbactam) Combination Against Extended-Spectrum Beta-Lactamase Producing Uropathogenic .头孢克洛/β-内酰胺酶抑制剂(克拉维酸和舒巴坦)联合用药对产超广谱β-内酰胺酶的尿路致病性病原菌的体外活性
Antibiotics (Basel). 2025 Jun 13;14(6):603. doi: 10.3390/antibiotics14060603.
4
Antibiotic synergy against : a systematic review and meta-analysis.抗生素协同作用:一项系统评价与荟萃分析
Antimicrob Agents Chemother. 2025 Aug 6;69(8):e0119924. doi: 10.1128/aac.01199-24. Epub 2025 Jun 17.
5
Synergistic Approaches to Foodborne Pathogen Control: A Narrative Review of Essential Oils and Bacteriophages.食源性病原体控制的协同方法:精油和噬菌体的叙述性综述
Foods. 2025 Apr 25;14(9):1508. doi: 10.3390/foods14091508.
6
Prevalence of colistin resistance in clinical isolates of : a systematic review and meta-analysis.临床分离株中黏菌素耐药性的流行情况:一项系统评价和荟萃分析。
Front Microbiol. 2024 Oct 9;15:1477836. doi: 10.3389/fmicb.2024.1477836. eCollection 2024.
7
Novel synergistic interactions between monolaurin, a mono-acyl glycerol and β lactam antibiotics against Staphylococcus aureus: an in vitro study.月桂酸单甘酯与β-内酰胺类抗生素对金黄色葡萄球菌的协同作用:体外研究。
BMC Infect Dis. 2024 Apr 8;24(1):379. doi: 10.1186/s12879-024-09261-9.
8
Bacteriological and molecular study of fosfomycin resistance in uropathogenic Escherichia coli.尿路致病性大肠埃希菌中磷霉素耐药性的细菌学和分子研究。
Braz J Microbiol. 2024 Jun;55(2):1091-1097. doi: 10.1007/s42770-024-01272-7. Epub 2024 Feb 17.
9
Assessing the Potential of Gallic Acid and Methyl Gallate to Enhance the Efficacy of β-Lactam Antibiotics against Methicillin-Resistant by Targeting β-Lactamase: In Silico and In Vitro Studies.通过靶向β-内酰胺酶评估没食子酸和没食子酸甲酯增强β-内酰胺类抗生素对耐甲氧西林菌疗效的潜力:计算机模拟和体外研究
Antibiotics (Basel). 2023 Nov 13;12(11):1622. doi: 10.3390/antibiotics12111622.
10
Fucoxanthin Potentiates the Bactericidal Activity of Cefotaxime Against Staphylococcus aureus.岩藻黄质增强头孢噻肟对金黄色葡萄球菌的杀菌活性。
Curr Microbiol. 2023 Jun 26;80(8):260. doi: 10.1007/s00284-023-03381-2.

本文引用的文献

1
Overview of Changes to the Clinical and Laboratory Standards Institute M100, 31st Edition.临床和实验室标准协会 M100,31 版更改概述。
J Clin Microbiol. 2021 Nov 18;59(12):e0021321. doi: 10.1128/JCM.00213-21. Epub 2021 Sep 22.
2
Emergence, molecular mechanisms and global spread of carbapenem-resistant .耐碳青霉烯肠杆菌科细菌的出现、分子机制和全球传播。
Microb Genom. 2019 Oct;5(10). doi: 10.1099/mgen.0.000306.
3
Fosfomycin in severe infections due to genetically distinct pan-drug-resistant Gram-negative microorganisms: synergy with meropenem.磷霉素在由遗传上不同的泛耐药革兰氏阴性微生物引起的严重感染中的应用:与美罗培南具有协同作用。
J Antimicrob Chemother. 2019 Jan 1;74(1):177-181. doi: 10.1093/jac/dky406.
4
Synergistic Activity of Colistin-Containing Combinations against Colistin-Resistant Enterobacteriaceae.黏菌素联合用药对黏菌素耐药肠杆菌科的协同作用
Antimicrob Agents Chemother. 2018 Sep 24;62(10). doi: 10.1128/AAC.00873-18. Print 2018 Oct.
5
In vitro activities of carbapenems in combination with amikacin, colistin, or fosfomycin against carbapenem-resistant Acinetobacter baumannii clinical isolates.碳青霉烯类药物与阿米卡星、黏菌素或磷霉素联合应用对耐碳青霉烯类鲍曼不动杆菌临床分离株的体外活性。
Diagn Microbiol Infect Dis. 2018 Jun;91(2):169-174. doi: 10.1016/j.diagmicrobio.2018.01.008. Epub 2018 Jan 31.
6
The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace.耐碳青霉烯类肠杆菌科细菌的流行病学:一种全球威胁的影响与演变
J Infect Dis. 2017 Feb 15;215(suppl_1):S28-S36. doi: 10.1093/infdis/jiw282.
7
Polymyxin B in combination with meropenem against carbapenemase-producing Klebsiella pneumoniae: pharmacodynamics and morphological changes.多黏菌素B联合美罗培南治疗产碳青霉烯酶肺炎克雷伯菌:药效学及形态学变化
Int J Antimicrob Agents. 2017 Feb;49(2):224-232. doi: 10.1016/j.ijantimicag.2016.10.025. Epub 2016 Dec 23.
8
In Vitro Synergistic Activity of Antimicrobial Agents in Combination against Clinical Isolates of Colistin-Resistant Acinetobacter baumannii.抗菌药物联合对耐黏菌素鲍曼不动杆菌临床分离株的体外协同活性
Antimicrob Agents Chemother. 2016 Oct 21;60(11):6774-6779. doi: 10.1128/AAC.00839-16. Print 2016 Nov.
9
Cefazolin and Ertapenem, a Synergistic Combination Used To Clear Persistent Staphylococcus aureus Bacteremia.头孢唑林与厄他培南联合使用具有协同作用,可用于清除持续性金黄色葡萄球菌菌血症。
Antimicrob Agents Chemother. 2016 Oct 21;60(11):6609-6618. doi: 10.1128/AAC.01192-16. Print 2016 Nov.
10
Antimicrobial synergy between carprofen and doxycycline against methicillin-resistant Staphylococcus pseudintermedius ST71.卡洛芬与强力霉素对耐甲氧西林中间型葡萄球菌ST71的抗菌协同作用。
BMC Vet Res. 2016 Jun 24;12(1):126. doi: 10.1186/s12917-016-0751-3.